Adult ID

Oral Abstract

97 - Innovations in Clinical Practice

Presentations:

• 3:15 PM - 3:30 PM

  888 - Impact of Mandatory Infectious Diseases Consult on All-Cause Inpatient Mortality and 30-day Readmission in Patients with Severe Sepsis
  Cindy Hou, DO, MA, MBA, FACOI – Jefferson Health - New Jersey; Todd P. Levin, DO, FACOI, FIDSA – Jefferson Health - New Jersey; Nikunj M. Vyas, PharmD, BCPS – Jefferson Health - New Jersey; Stefanie Deangelo, BSN, MLA, RN, CMSRN – Jefferson Health - New Jersey; Jean Klepka, BSN, BA, RN, CMSRN – Jefferson Health - New Jersey; Dawne Piotrowicz, MSN, RN – Jefferson Health - New Jersey
• 3:30 PM - 3:45 PM

  889 - Impact of an Infectious Disease Telehealth (IDt) Service on S. aureus Bacteremia (SAB) Outcomes in 15 Small Community Hospitals
  Alithea D. Gabrellas, MD – University of Utah; John J. Veillette, PharmD – Intermountain Healthcare; Brandon J. Webb, MD – Intermountain Healthcare; Edward A. Stenehjem, MD, MSc – Intermountain Healthcare; Nancy A. Grisel, Master of Public Administration – Intermountain Healthcare; Todd J. Vento, MD, MPH – Intermountain Healthcare
• 3:45 PM - 4:00 PM

  890 - Bridging the Gap to Help Address the Opioid Crisis: A Novel Model of Care to Integrate Substance Use, Mental Health, and Infectious Disease Services
  Kimberly Corace, PhD – University of Ottawa; Nicholas Schubert, MA – The Royal Ottawa Mental Health Centre; Melanie Willows, MD – University of Ottawa; Guy Herbert, MD – University of Ottawa; Gary Garber, MD – University of Ottawa
• 4:00 PM - 4:15 PM

  891 - Epidemiology and Outcomes of Sepsis in Previously Healthy Patients
  Mohammad Alrawashdeh, PhD, MSN – Harvard Medical School; Michael Klompas, MD, MPH – Harvard Medical School; Steven Q. Simpson, MD – University of Kansas Medical Center; Sameer S. Kadri, MD, MS – National Institutes of Health; Russell Poland, PhD – HCA Healthcare; Kenneth Sands, MD, MPH – HCA Healthcare; Chanu Rhee, MD, MPH – Harvard Medical School
• 4:15 PM - 4:30 PM

  892 - Risk Factors for Adverse Events in Children Receiving Outpatient Antibiotic Therapy
  Elizabeth Townsley, MD, PhD – Vanderbilt University Medical Center; Jessica Gillon, PharmD – Vanderbilt University Medical Center; Natalia Jimenez-Truque, MSCI, PhD – Vanderbilt University Medical Center; Kathryn Garguilo, MSN, RN – Vanderbilt University Medical Center; Ritu Banerjee, MD, PhD – Vanderbilt University Medical Center

Co-Author(s)

• MA

  Mohammad Alrawashdeh, PhD, MSN

  Postdoctoral Research Fellow
  Harvard Medical School
  Boston, MA

  Disclosure: Nothing to disclose
• CH

  Cindy Hou, DO, MA, MBA, FACOI

  Infectious Diseases Atending Physician
  Jefferson Health - New Jersey
  Voorhees, NJ

  Disclosure: Nothing to disclose
• JG

  Jessica Gillon, PharmD

  Pharmacist
  Vanderbilt University Medical Center
  Nolensville, TN
• MK

  Michael Klompas, MD, MPH

  Professor
  Harvard Medical School
  Boston, MA

  Disclosure: Nothing to disclose
• TL

  Todd Levin, DO, FACOI, FIDSA

  Infectious Diseases Atending Physician
  Jefferson Health - New Jersey
  Voorhees, NJ

  Disclosure: Nothing to disclose
• NS

  Nicholas Schubert, MA

  Program Evaluation Coordinator
  The Royal Ottawa Mental Health Centre
  Ottawa, ON, Canada

  Disclosure: Nothing to disclose
• JV

  John Veillette, PharmD

  Pharmacist
  Intermountain Healthcare
  Murray, UT

  Disclosure: Nothing to disclose
• NJ

  Natalia Jimenez-Truque, MSCI, PhD

  Research Assistant Professor
  Vanderbilt University Medical Center
  Nashville, TN

  Disclosure: Nothing to disclose
• SS

  Steven Simpson, MD

  Professor
  University of Kansas Medical Center
  Kansas City, KS

  Disclosure: Nothing to disclose
• BW

  Brandon Webb, MD

  Director, Transplant Infectious Diseases
  Intermountain Healthcare
  Murray, UT

  Disclosure: Astellas Pharma Global, Inc: Grant/Research Support
• MW

  Melanie Willows, MD

  Clinical Director
  University of Ottawa
  Ottawa, ON, Canada

  Disclosure: Nothing to disclose
• SD

  Stefanie Deangelo, BSN, MLA, RN, CMSRN

  Clinical Quality Manager
  Jefferson Health - New Jersey
  Turnersville, NJ

  Disclosure: Nothing to disclose
• KG

  Kathryn Garguilo, MSN, RN

  Clinical Nurse Specialist
  Vanderbilt University Medical Center
  Nashville, TN

  Disclosure: Nothing to disclose
• GH

  Guy Herbert, MD

  Head, Department of Emergency
  University of Ottawa
  Ottawa, ON, Canada

  Disclosure: Nothing to disclose
• SK

  Sameer Kadri, MD, MS

  Head, Clinical Epidemiology Section, Critical Care Medicine Department
  National Institutes of Health
  Bethesda, MD

  Disclosure: Nothing to disclose
• 

  Edward Stenehjem, MD, MSc

  Medical Director of Antibiotic Stewardship
  Intermountain Healthcare
  Salt Lake City, UT

  Disclosure: CDC: Grant/Research Support
• 

  Ritu Banerjee, MD, PhD

  Associate Professor
  Vanderbilt University Medical Center
  Nashville, Tennessee

  Disclosure: Accelerate Diagnostics: Grant/Research Support
  BioFire: Research Grant
  Biomerieux: Research Grant
  Roche: Research Grant
• GG

  Gary Garber, MD

  Chief, Infection and Prevention Control
  University of Ottawa
  Toronto, ON, Canada

  Disclosure: Nothing to disclose
• NG

  Nancy Grisel, Master of Public Administration

  Sr. Statistical Data Analyst
  Intermountain Healthcare
  Murray, UT

  Disclosure: Nothing to disclose
• JK

  Jean Klepka, BSN, BA, RN, CMSRN

  Clinical Quality Manager
  Jefferson Health - New Jersey
  Turnersville, NJ

  Disclosure: Nothing to disclose
• RP

  Russell Poland, PhD

  Chief Research Officer
  HCA Healthcare
  Nashville, TN

  Disclosure: Nothing to disclose
• DP

  Dawne Piotrowicz, MSN, RN

  Corporate Director of Clinical Initiatives
  Jefferson Health - New Jersey
  Turnersville, NJ

  Disclosure: Nothing to disclose
• KS

  Kenneth Sands, MD, MPH

  Chief Patient Safety Officer
  HCA Healthcare
  Nashville, TN

  Disclosure: Nothing to disclose
• TV

  Todd Vento, MD, MPH

  Medical Director, Infectious Diseases TeleHealth Service
  Intermountain Healthcare
  Murray, UT

  Disclosure: Nothing to disclose

Moderator(s)

• TF

  Tom File, MD

  Chair, Infectious Disease Division
  Summa Health System
  Akron, OH

  Disclosure: Merck: Advisory Board, Consultant
  MotifBio: Advisory Board, Consultant
  Paratek Pharmaceuticals: Advisory Board, Consultant
  Shionogi: Advisory Board, Consultant
• 

  Ann MacIntyre, DO, MHS, FIDSA

  Physician
  Private Practice
  Miami, FL

  Disclosure: Nothing to disclose

Presenting Author(s)

• KC

  Kimberly Corace, PhD

  Director of Clinical Programming and Research
  University of Ottawa
  Ottawa, ON, Canada

  Disclosure: Nothing to disclose
• AG

  Alithea Gabrellas, MD

  Infectious Disease Fellow
  University of Utah
  Salt Lake City, UT

  Disclosure: Nothing to disclose
• ET

  Elizabeth Townsley, MD, PhD

  Internal Medicine-Pediatrics, PGY-3
  Vanderbilt University Medical Center
  Nashville, TN
• NV

  Nikunj Vyas, PharmD, BCPS

  Clinical Pharmacist/Infectious Diseases
  Jefferson Health - New Jersey
  Marlton, NJ

  Disclosure: Nothing to disclose
• 

  Chanu Rhee, MD, MPH

  Assistant Professor
  Harvard Medical School
  Boston, Massachusetts

  Disclosure: UpToDate: Royalties (for authoring Procalcitonin chapter)